Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 11 of 25

COMPLETED

Hypertension Management Using Remote Patient Monitoring

NCT05562921

COMPLETED

The Impact of Pediatric Skin Disorders: The "Big" Study

NCT03544866

TERMINATED Phase 2

Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer

NCT03723915

COMPLETED

Genetic Analysis of Pediatric Psoriasis

NCT03768284

COMPLETED NA

Lessons in Affect Regulation to Keep Stress and Pain UndeR Control (LARKSPUR R34)

NCT03699553

TERMINATED NA

High Intensity Walking to Reduce Frailty

NCT03709251

COMPLETED Phase 3

Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease

NCT03743636

TERMINATED NA

Empowering Veterans to Communicate With Healthcare Providers

NCT03529071

COMPLETED NA

Reducing Assessment Barriers for Patients With Low Literacy

NCT03584490

COMPLETED NA

Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders

NCT03623880

COMPLETED NA

Promotora-Led Intervention for Metabolic and Mental Health

NCT03372018

COMPLETED

Skin Tone Preferences and Their Influence on Skin Care Behaviors

NCT03651167

COMPLETED Early Phase 1

MRI Study of Noninvasive Transcranial Electrical Stimulation in Tinnitus

NCT03544359

COMPLETED Phase 4

CESI With Low Dose Lidocaine and Transient Weakness

NCT03127137

COMPLETED NA

Wellness For 2: A Feasibility and Acceptability Pilot

NCT03615261

COMPLETED

Sweat Sensors for Athletic Performance

NCT03566381

COMPLETED NA

Response of the Gut Microbiome and Circulating Metabolome to Diet in Children: Ancillary Study to KIDFIT (NCT03405246)

NCT03612479

COMPLETED NA

Examining the Effects of Juice Fasting

NCT03647449

COMPLETED NA

UV Exposure Assessed With Wearable Sensor and Sun Protection

NCT03344796

COMPLETED

Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD

NCT03438032

COMPLETED Phase 4

Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries

NCT03470675

COMPLETED NA

Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications

NCT03633682

COMPLETED NA

Opiate Prescribing Guidelines Following Hip Arthroscopy

NCT04169113

COMPLETED NA

Redesigning Systems to Improve Quality for Hospitalized Patients

NCT03745677

COMPLETED NA

Skin Self-Examination Education During Mammography

NCT03512457

TERMINATED Phase 2

Cardiac Safe Transplants for Systemic Sclerosis

NCT03593902

COMPLETED NA

Strengthening Circadian Signals

NCT03490864

COMPLETED NA

Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial

NCT03104868

COMPLETED NA

Set Your Goal: Engaging Go/No-Go Active Learning

NCT03538535

COMPLETED NA

Supporting All Families of Premature Infants At Prentice Women's Hospital from Admission Through Discharge

NCT03505424

COMPLETED NA

A Pragmatic Trial of An Adaptive eHealth HIV Prevention Program for Diverse Adolescent MSM

NCT03511131

COMPLETED Phase 2

Online HIV Prevention for Young Male Couples

NCT03284541

COMPLETED

Maternal Non-Stress Testing

NCT04343482

COMPLETED NA

Administration Method of Cognitive Screening in Older Individuals With Hearing Loss

NCT03402932

TERMINATED Phase 2

D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain

NCT03535688

TERMINATED Phase 4

Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia

NCT03511521

COMPLETED NA

Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction

NCT03876743

COMPLETED NA

South Asian Healthy Lifestyle Initiative (SAHELI)

NCT03336255

COMPLETED NA

Aging Program Project Grant 6

NCT03490825

COMPLETED

Pressure and Temperature Sensor for Therapeutic Compression Garments

NCT03461549

COMPLETED NA

Development, Feasibility and Acceptability of Fathers and Babies (FAB): A Pilot Study

NCT03427528

COMPLETED NA

Bilateral Priming Plus Task Specific Training for Severe Upper Limb Hemiparesis

NCT03517657

TERMINATED Phase 4

Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion

NCT03151746

COMPLETED NA

Regimen Education and Messaging in Diabetes (REMinD)

NCT03185741

COMPLETED NA

txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men

NCT02994108

COMPLETED Phase 2

Hepatocyte Growth Factor to Improve Functioning in PAD

NCT03363165

TERMINATED NA

Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat

NCT03284034

TERMINATED Phase 3

Maximizing Outcome of Multiple Sclerosis Transplantation

NCT03342638

COMPLETED NA

Diabetes Risk Education and Communication Trial

NCT03283657

COMPLETED

Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy

NCT03191604

← Previous Page 11 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.